Ascendis, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals,
Novo Nordisk, Sanofi, and Teva to keynote sharing innovations to
drive better patient outcomes
BARCELONA, Spain, May 21, 2024 /PRNewswire/ -- Veeva Systems (NYSE:
VEEV) today announced that leaders from Ascendis Pharma A/S, Bayer,
Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk, Sanofi,
and Teva will be keynote speakers at Veeva R&D and Quality
Summit, Europe, June 4-5 in Madrid,
Spain. Life sciences professionals across the industry will
come together to share how connected technologies across clinical,
regulatory, safety, and quality are advancing innovations for
patients.
As one of the largest gatherings of biopharma leaders in
Europe, Veeva R&D and Quality
Summit will bring together over 1,000 industry professionals to
share learnings across more than 100 sessions. Bayer and Jazz
Pharmaceuticals will join Rik Van Mol, senior vice president of
Veeva Development Cloud, and Avril
England, general manager of Veeva Vault, for the opening
keynote to explore the future of development for new medicines and
therapies.
The event's zone keynotes include:
- Ascendis and Bayer, sharing strategies to reduce costs
and accelerate trials with a connected platform.
- Boehringer Ingelheim, detailing its shift toward
data-centric regulatory information management.
- Novo Nordisk, showing how it uses data and AI to
transform clinical research.
- Sanofi, explaining its innovative approach to advance
quality through operational excellence.
- Teva, providing insight into its rapid journey from
disparate safety systems into one streamlined global solution.
A panel with Elpida Therapeutics CEO Terry Pirovolakis and Veeva experts will close
the event with a discussion on how the industry can best accelerate
the development of life-saving rare disease gene therapies.
"Connecting clinical, regulatory, safety, and quality is key to
advancing the product lifecycle and delivering better outcomes for
patients," says Rik Van Mol, senior vice president of Veeva
Development Cloud. "At Veeva R&D and Quality Summit, biopharma
leaders can connect, exchange ideas, and share new strategies to
advance the industry forward together."
Veeva R&D and Quality Summit is open exclusively to life
sciences professionals. Register and review the agenda
at veeva.com/eu/Summit.
Additional Information
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-K for the fiscal year ended January 31, 2024, which you can
find here (a summary of risks which may impact our
business can be found on pages 9 and 10), and in our subsequent SEC
filings, which you can access at sec.gov.
Contact:
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/biopharma-leaders-shape-the-future-of-drug-development-at-veeva-rd-and-quality-summit-europe-302150491.html